Cervarix vaccine [human papillomavirus vaccine MEDI-517] has been granted WHO prequalification in developing nations

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.583, 2009-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human papillomavirus vaccine MEDI-517: Acute disseminated encephalomyelitis: case report

Reactions Weekly, Vol. 1, Iss. 1246, 2009-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Human papillomavirus vaccine MEDI-517: Various toxicities: 11 case reports

Reactions Weekly, Vol. 1, Iss. 1329, 2010-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Sanofi Pasteur MSD's recombinant quadrivalent human papillomavirus (HPV) vaccine [Gardasil] has been launched in 15 EU countries

Inpharma, Vol. 1, Iss. 1575, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Human papillomavirus types 16 and 18 vaccine (Cervarix™): a guide to its use in the prevention of cervical cancer

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 24, Iss. 6, 2008-06 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Human Papillomavirus Types 16 and 18 Vaccine (Recombinant, AS04 Adjuvanted, Adsorbed) [Cervarix™]

By Keam Susan J.

Drugs, Vol. 68, Iss. 3, 2008-01 ,pp. : 359-372

Adis International

Access to resources Recommend Favorite